Catalyst Wire Dossier Catalyst Wire Dossier

TAK-020

· Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAK-020, covering 2018-04-13 to 2019-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy Volunteers [Phase 1]

See pricing